Facebook Twitter YouTube  
Contact Us
Search Clinical Trials
Home > Clinical Trials & Research > Search Clinical Trials
Print

Clinical Trials & Research

Search Clinical Trials

Clinical Trials

New Search
Title Principal Investigator Post Date
A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions. Anna Bortnick, MD, PhD   
A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes (GRADE) Jill Crandall, MD   
A Comparative Evaluation of the Safety and Efficacy of Daptomycin Versus Standard of Care in Pediatric Subjects Two - Seventeen Years of Age With Bacteremia Caused by Staphylococcus Aureus Tsoline Kojaoglanian, MD   
A Dose Finding Study of Eribulin Mesylate and Cetuximab For Patients With Advanced Head and Neck and Colon Cancer Missak Haigentz, MD   
A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With HF and Left Ventricular Systolic Dysfunction Julia Shin, MD   
A Feasibility Study Evaluating the Ability of Patients with Epilepsy to use a Proprietary Breath-Actuated Pressurized Metered-Dose Inhaler Alexis Boro, MD   
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes Jill Crandall, MD    
A Multicenter, Double-blind, Placebo-controlled Phase 3 Study Assessing the Safety and Efficacy of Selexipag on Morbidity and Mortality in Patients With Pulmonary Arterial Hypertension Dr. James M. Tauras, MD   
A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction Ileana L. Piña, MD, MPH   
A Multicenter, Randomized, Double-blind, Placebo Controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients Dr. James M. Tauras, MD   
A patient registry for monitoring long-term safety and efficacy of IncrelexTM Ping Zhou, MD   
A Phase 1, Multicenter, Open-label Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI0680 (AMP-514) in Subjects With Advanced Malignancies Sanjay Goel, MD   
A Phase 2 Study Of Dacomitinib In Advanced Non-Small Cell Lung Cancer (Post-Chemotherapy Or Select First Line Patients) To Evaluate Prophylactic Intervention On Dermatologic And Gastrointestinal Adverse Events And Patient Reported Outcomes Bilal Piperdi, MD   
A Phase 2 Study of Fosbretabulin in Subjects With Gastrointestinal Neuroendocrine Tumors (GI-NET) and With Elevated Biomarkers Steven Libutti, MD    
A Phase 2, Multicenter, Randomized, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Noah Kornblum, MD   
A Phase 2b, Double-Blind, Placebo-Controlled, Multinational, Multicenter, Randomized Study Evaluating the Safety and Efficacy of Intracoronary Administration of MYDICAR® (AAV1/SERCA2a) in Subjects With Heart Failure Dr. James M. Tauras, MD   
A Phase I/II Evaluation of ADXS11-001, Mitomycin, 5-fluorouracil (5-FU) and IMRT for Anal Cancer (276) Lakshmi Rajdev, MD    
A Phase II Randomized, Multicenter Study of Treatment-free Remission in Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Patients Who Achieve and Sustain MR4.5 After Switching to Nilotinib Olga Derman, MD   
A Phase II Study of Sodium Cridanimod in Conjunction With Progestin Therapy in Patients With Progesterone Receptor Negative Recurrent or Persistent Endometrial Carcinoma Nicole Nevandusky, MD    
A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + TAK-700 With Androgen Deprivation Therapy + Bicalutamide in Patients With Newly Diagnosed Metastatic Sensitive Prostate Cancer Benjamin Gartrell, MD   
A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi (BELLE-3) Eleni Andreopoulou, MD    
A pilot randomized trial comparing arm circumference and bioimpedence measurement for early detection and treatment of lymphedema in patients undergoing axillary lymph node dissection or sentinel node biopsy Lisa Wiechmann, MD   
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome Jessica M. Peña, MD, MPH   
A Registry to Assess the Ongoing Safety for Subjects That Have Been Randomized and Completed a Juventas Sponsored Heart Failure Protocol Under IND # 14203 Julia Shin, MD   
A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241 AM3) (SPIRO) Golda Hudes, MD   
A Study of ARN-509 in Men With Non-Metastatic Castration-Resistant Prostate Cancer (SPARTAN) Benjamin Gartrell, MD    
A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination With Crizotinib. Bilal Piperdi, MD   
A Study of Gemcitabine and Nab-paclitaxel With or Without NPC-1C to Treat Patients With Pancreatic Cancer Santiago Aparo, MD    
A Study of Inhaled Vidaza in Advanced Non-Small Cell Lung Lung Cancer Patients Bilal Piperdi, MD   
A Study of MEK162 vs. Physician's Choice Chemotherapy in Patients With Low-grade Serous Ovarian, Fallopian Tube or Peritoneal Cancer Gloria Huang, MD   
A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease (SCD) Deepa Manwani, MD   
A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders Eric Hollander, MD   
A Study of Tarceva Before Surgery in Non-Small Cell Lung Cancer Patients Who Have EGFR Positive Tumors. (EVENT) Bilal Piperdi, MD   
A Study of the Safety and Efficacy of CMX001 for the Prevention of Cytomegalovirus (CMV) Infection in CMV-seropositive (R+) Hematopoietic Stem Cell Transplant Recipients Olga Derman, MD    
A Study to Evaluate the Efficacy and Safety of VX-765 in Subjects With Treatment-Resistant Partial Epilepsy Alexis Boro, MD   
A Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide Sanjay Goel, MD   
A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM3) Sanjay Goel, MD   
A Study Using MABp1 To Increase Overall Survival In Patients With Colorectal Cancer And Weight Loss Sanjay Goel, MD   
A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia (ASPIRE) Amit Verma, MD   
Adjuvant Axitinib Therapy of Renal Cell Cancer in High Risk Patients (ATLAS) Benjamin Gartrell, MD   
Adult Congenital Heart Disease Quality Enhancement Research Initiative (ACHD-QuERI) Ali Zaidi, MD   
Afatinib After Chemoradiation and Surgery in Treating Patients With Stage III-IV Squamous Cell Carcinoma of the Head and Neck at High-Risk of Recurrence Missak Haigentz, MD   
Alisertib, Bortezomib, and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or B-cell Low Grade Non-Hodgkin Lymphoma Noah Kornblum, MD   
An Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Eric Hollander, MD   
An Intervention to Improve ICD Deactivation Conversations (WISDOM - Working to Improve discuSsions About DefibrillatOr Management) Hannah I. Lipman, MD   
An Observational Study in Patients With Asthma Initiating Treatment With Xolair (Omalizumab) Golda Hudes, MD   
An Observational, Multi-center, Multi-National, Long term Follow-Up study of Atypical Hemolytic Uremic syndrome (aHUS) Patients treated with Eculizumab in a prior clinical study Beatrice Goilav, MD   
An Open Label Multi-center Extension Study to Evaluate Long-term Safety/ Tolerability of Dovitinib in Patients With Solid Tumors Who Continue to Receive Treatment With Dovitinib (TKI258) in Novartis-sponsored Single Agent Dovitinib Studies Sanjay Goel, MD    
An Open-Label Study of the Effect of Telaprevir in Combination With Peginterferon Alfa-2b and Ribavirin in Pediatric Subjects Infected With Hepatitis C Virus Debra Pan, MD   
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain Veronica Carullo, MD   
Anal HPV Tests in Screening for Cell Changes in the Anus in Patients With HIV Mark Einstein, MD   
ANCHOR (Aneurysm Treatment Using the HeliFX Aortic Securement System Global Registry) Evan Lipsitz, MD   
Assess Safety and Efficacy of ELAD (Extracorporeal Liver Assist System) in Subjects With Alcohol-Induced Liver Failure Paul Gaglio, MD   
Atypcial Hemolytic-Uremic Syndrome (aHUS) Registry Frederick Kaskel, MD   
Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer Missak Haigentz, MD   
Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors Mary Welch, MD    
Bi-Level Positive Airway Ventilation for Acute Chest Syndrome Deepa Manwani, MD   
BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis (ATLAS) Chaim Putterman, MD   
Breast Metastatic- Chemotherapy Joseph Sparano, MD   
Brexpiprazole as an Additional Treatment to Paroxetine or Sertraline in Adult Patients Suffering From Post-traumatic Stress Disorder (PTSD) Eric Hollander, MD   
Cabozantinib-S-Malate in Treating Patients With Advanced Solid Tumors and Human Immunodeficiency Virus Missak Haigentz, MD   
Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer Benjamin Gartrell, MD   
CaMEO Study: Chronic Migraine Epidemiology and Outcomes Study Dawn Buse, MD   
Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial Dr. Eugen C. Palma, MD   
Chemotherapy Before Surgery and Tissue Sample Collection in Patients With Stage IIA-IIIC Breast Cancer Eleni Andreopoulou, MD   
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer Missak Haigentz, MD   
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Christine Pellegrino, MD   
Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer or Metastatic Large Cell Neuroendocrine Non-Small Cell Lung Cancer Bilal Piperdi, MD   
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia Olga Derman, MD   
Combination Chemotherapy, Gemcitabine Hydrochloride, and Radiation Therapy Before Surgery in Treating Patients With Borderline Resectable Pancreatic Cancer Jennifer Chuy, MD   
Combination Study of Deferasirox and Erythropoietin in Patients With Low- and Int-1-risk Myelodysplastic Syndrome. Olga Derman, MD   
Comparison of Cabazitaxel/Prednisone Alone or in Combination With Custirsen for 2nd Line Chemotherapy in Prostate Cancer (AFFINITY) Sanjay Goel, MD   
CORRONA Data Collection Program Anna Broder, MD   
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure Julia Shin, MD   
Cyclophosphamide With or Without Veliparib in Patients With Locally Advanced or Metastatic Breast Cancer Eleni Andreopoulou, MD    
Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia Olga Derman, MD   
Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study Kris Mahadeo, MD   
Dexamethasone Infusion to the Adventitia to Enhance Clinical Efficacy After Femoropopliteal Revascularization David P. Slovut, MD, PhD   
Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer Madhur Garg, MD    
E2108 Early Local Therapy for the Intact Primary Tumor in Patients with Metastatic Breast Cancer Lisa Wiechmann, MD  11/22/2011 
Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer Lisa Weichmann, MD   
ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas Ramakrishna Battini, MD   
Efficacy and Safety of BEZ235 Compared to Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumors (MACS1938) Steven K. Libutti, MD   
Efficacy and Safety of Idelalisib (GS-1101) in Combination With Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas (Yosemite) Ramakrishna Battini, MD   
Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or Decitabine Amit Verma, MD    
Efficacy and Safety of Trichuris Suis Ova (TSO) as Compared to Placebo in Autism Spectrum Disorder Eric Hollander, MD   
Efficacy and Safety of Ularitide for the Treatment of Acute Decompensated Heart Failure (TRUE-AHF) Snehal R. Patel, MD   
Eisenmenger Quality Enhancement Research Initiative (ES-QuERI) Ali Zaidi, MD   
Erlotinib Hydrochloride Before Surgery in Treating Patients With Stage III Non-Small Cell Lung Cancer Bilal Piperdi, MD   
Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer Yijuan Hou, MD   
Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery Steven Libutti, MD    
EXCOR® Pediatric Ventricular Assist Device Post Approval Study Samuel Weinstein, MD   
Exemestane With or Without Entinostat in Treating Postmenopausal Patients With Recurrent Hormone Receptor-Positive Breast Cancer That Is Locally Advanced or Metastatic Christine Pellegrino, MD    
EXPAREL Administered by Infiltration Into the TAP for Prolonged Postsurgical Analgesia in Lower Abdominal Surgeries (TRANSCEND) Boleslav Kosharshkyy, MD    
Exploratory Study Of The ERCC-1 Gene Expression In Colorectal Cancer Cell Lines And In Patients With Colorectal Cancer Sanjay Goel, MD   
Factors Affecting Patient Participation in AIDS Malignancy Clinical Trials Consortium Clinical Trials Missak Haigentz, MD   
FOLFOX6m Plus SIR-Spheres Microspheres vs FOLFOX6m Alone in Patients With Liver Mets From Primary Colorectal Cancer (FOXFIREGlobal) Andreas Kaubisch, MD   
Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery Christine Pellegrino, MD   
Fulvestrant With or Without Bortezomib in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer Christine Pellegrino, MD   06/10/2010 
Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure. Ileana L. Piña, MD, MPH   
Human Epilepsy Project Sheryl Haut, MD   
IK-5001 for the Prevention of Remodeling of the Ventricle and Congestive Heart Failure After Acute Myocardial Infarction (PRESERVATION 1) Anna Bortnick, MD, PhD   
Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T (PRIME) Sanjay Goel, MD   
Immunotoxin Therapy and Cytarabine in Treating Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia Amit Verma, MD   
INcrease Of VAgal TonE in CHF (INOVATE-HF) - A Randomized Study to Establish the Safety and Efficacy of CardioFit® for the Treatment of Subjects With Heart Failure and Left Ventricular Dysfunction Snehal Patel, MD   
International Guillain-Barré Syndrome Outcome Study (IGOS) Volkan Granit, MD   
Intra-patient Dose Escalation Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients With Dumping Syndrome Anirban Gupta, MD   
Intracardiac Cryoablation for AtrioVentricular Nodal Reentrant Tachycardia Andrew Krummerman, MD   
Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery Stuart Packer, MD   
KW 0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL) Murali Janakiram, MD    
Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia Who Have Undergone Stem Cell Transplant Ira Braunschweig, MD    
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia Amit Verma, MD   
Loteprednol vs Prednisolone for the Treatment of Intraocular Inflammation Following Cataract Surgery in Children. Norman Medow, MD   
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy Missak Haigentz, MD   
Meditation-Based Breathing Training in Improving Target Motion Management and Reducing Distress in Patients With Abdominal or Lung Cancer Undergoing Radiation Therapy Alyson Moadel, PhD    
Modifiers of PrEP Efficacy: Impact of the Vaginal Microbiome and Age Marla Keller, MD   
MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer Beatriu Reig, MD    
MSB0010718C in Solid Tumors Sanjay Goel, MD   
Natural History of Brain Function, Quality of Life, and Seizure Control in Patients With Brain Tumor Who Have Undergone Surgery Mary Welch, MD    
Natural History Study of the Development of Type 1 Diabetes Chhavi Agarwal, MD   
Neurocognitive Effects of Opiate Agonist Treatment (NEO) Julia Arnsten, MD   
Nocturnal Migraine and Sleep: Stage 1, Patient Questionnaire and Recruitment Study Richard Lipton, MD   
Non-invasive Neurostimulation of the Vagus Nerve for the Treatment of Cluster Headache (CH) Brian Grosberg, MD   
Noninvasive and Continuous Hemoglobin Monitoring for Surgical Blood Management (NACHO) Ellise Delphin, MD    
Observational Study of Real World Effectiveness Data and Safety in Patients Receiving Pazopanib With Advanced or Metastatic Renal Cell Carcinoma (PRINCIPAL) Benjamin Gartrell, MD    
Occipital Nerve Stimulation (ONS) for Migraine: OPTIMISE Brian Grosberg, MD   
ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab SAR236553 (REGN727) Anna Bortnick, MD, PhD   
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Sanjay Goel, MD   
Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery Benjamin Gartrell, MD    
Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors Steven Libutti, MD    
Pediatric Autism Study Eric Hollander, MD   
Pediatric Lupus Trial of Belimumab Plus Background Standard Therapy (PLUTO) Dawn Wahezi, MD   
PET-Adjusted Intensity Modulated Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II-IV Non-Small Cell Lung Cancer (PAINT) Nitin Ohri, MD   
Pharmacokinetics, Efficacy,Safety of Abatacept Administered Subcutaneously in Children and Adolescents With Active Polyarticular Juvenile Idiopathic Arthritis and Inadequate Response to Biologic or Non Biologic Disease Modifying Anti-rheumatic Drugs Norman Ilowite, MD   
Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors Bilal Piperdi, MD   
Phase 2 Study of Inhaled Lipid Cisplatin in Pulmonary Recurrent Osteosarcoma Richard Gorlick, MD   
Phase II Randomized Trial Comparing GA101 and Rituximab in Untreated Low Tumor Burden Indolent Non-Hodgkin's Lymphoma (PrE0401) Noah Kornblum, MD    
Phase II Study of Ipilimumab Monotherapy in Recurrent Platinum Sensitive Ovarian Cancer Patients Mark Einstein, MD   
Phase II Study of Lenalidomide and Eltrombopag in Patients with Symptomatic Anemia in Low or Intermediate I Myelodysplastic Syndrome Amit Verma, MD   
Phase II Trial of Rituximab In Myasthenia Gravis Volkan Granit, MD    
Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia Ira Braunschweig, MD   
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma (ACT IV) Jerome Graber, MD   
Pilot Study to Evaluate the Safety and Biological Effects of Orally Administered Reparixin in Early Breast Cancer Patients Joseph Sparano, MD   
Placebo-Controlled Study to Evaluate the Safety and Efficacy of OPN-305 in Preventing Delayed Renal Graft Function Liise Kayler, MD   
Prevention of Sudden Death After Myocardial Infarction Using a LifeVest Wearable Cardioverter-defibrillator Jay N. Gross, MD   
ProMRI Study of the Entovis Pacemaker System (Phase B) Kevin J. Ferrick, MD   
ProMRI Study of the Iforia ICD System (Phase C) Kevin J. Ferrick, MD   
Prospective, Multi Centre, International Registry of Male and Female Patients Newly Diagnosed With Atrial Fibrillation Kevin J. Ferrick, MD   
Radiation Therapy With or Without Chemotherapy in Patients With Stage I or Stage II Cervical Cancer Who Previously Underwent Surgery Mark Einstein, MD   
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Madhur Garg, MD    
Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Lakshmi Rajdev, MD   
Remission From Stage D Heart Failure (RESTAGE-HF) Snehal R. Patel, MD   
Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma Ramakrishna Battini, MD   
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer (e3) Della Makower, MD    
Safety and Efficacy of Fidaxomicin Versus Placebo for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation (DEFLECT-1) Ramakrishna Battini, MD   
Safety of E-101 Solution for Preventing Surgical Site Infections After Colorectal Surgery (Triple IN) Arnold Berlin, MD   
Safety Study of Intratumoral Injection of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies Sanjay Goel, MD    
Safety, Tolerability and Activity Study of Ibudilast in Subjects With Progressive Multiple Sclerosis Jerome Graber, MD   
SILVER-AMI: Risk Stratification in Older Persons With Acute Myocardial Infarction Cynthia Taub, MD   
Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer Andreas Kaubisch, MD   
Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease (EUCLID) Francis Porreca, MD   
Study Comparing Combination of LGX818 Plus MEK162 and LGX818 Monotherapy Versus Vemurafenib in BRAF Mutant Melanoma (COLUMBUS) Stuart Packer, MD   
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED) Mark Einstein, MD    
Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea Paul Riska, MD   
Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer.(MONALEESA-2) Joseph Sparano, MD   
Study of Fulvestrant +/- Everolimus in Post-Menopausal, Hormone-Receptor + Metastatic Breast Ca Resistant to AI (PrE0102) Della Makower, MD    
Study of REOLYSIN® in Combination With FOLFIRI and Bevacizumab in FOLFIRI Naive Patients With KRAS Mutant Metastatic Colorectal Cancer Sanjay Goel, MD   
Study of REOLYSIN® in Combination With FOLFIRI in Patients With Oxaliplatin Refractory/Intolerant KRAS Mutant Colorectal Cancer Sanjay Goel, MD  01/07/2011 
Study of Ruxolitinib in Pancreatic Cancer Patients (Janus 1) Jennifer Chuy, MD   
Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer Bilal Piperdi, MD   
Study to Evaluate Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women Robert Grossberg, MD   
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters Alexis Boro, MD   
Study to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure Clusters (ARTEMIS1) Alexis Boro, MD   
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting (SIMPLICITY) Olga Derman, MD   
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Christine Pellegrino, MD  01/06/2011 
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Christine Pellegrino, MD   
Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors Steven Libutti, MD    
The Randomized Evaluation of VAD InterVEntion Before Inotropic Therapy (REVIVE-IT) Julia Shin, MD   
The Targeting Acute Congestion With Tolvaptan In Congestive Heart Failure Study Dr. James M. Tauras, MD   
Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide Nitin Ohri, MD   
Tracking & Feedback Registry to Reduce Breast Cancer Treatment Disparities Leslie Montgomery, MD    
Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer Missak Haigentz, MD   
Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males Mark Einstein, MD   
Validation of a kinase involved in innate immunity and biomarkers of its activity in SLE through ex vivo whole blood assays Dawn Wahezi, MD   
Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction Sanjay Goel, MD   
Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas Murali Janakiram, MD   
Vorinostat in Combination With Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection Missak Haigentz, MD